Skip to main content
. 2017 May 9;7:157. doi: 10.3389/fcimb.2017.00157

Figure 3.

Figure 3

Characterization of prM-AIDs. (A) The titer of prM-AIDs in immunizzed sera were determined by ELISA every 2 weeks (n = 6). Dilution of immunized or naive mouse sera were coated in 96-well plates. Biotinylated prM mAb were added. Bound prM mAb was detected by addition of streptavidin-HRP. (B) Purified prM-AIDs was identified by SDS-PAGE. (C) The specificity of prM-AIDs was analyzed by ELISA. Diluted naive mouse antibodies (NM-Abs), or immunized mouse antibodies (IM-Abs) were coated in 96-well plates. Biotinylated prM mAb were added. Bound prM mAb was detected by addition of streptavidin-HRP. Dotted line shows samples were considered positive if Positive/Native ration>2.1.